Corbus Pharmaceuticals
CRBP
#10362
Rank
โ‚ฌ38.69 M
Marketcap
1,88ย โ‚ฌ
Share price
-15.40%
Change (1 day)
-81.99%
Change (1 year)

EPS for Corbus Pharmaceuticals (CRBP)

EPS in 2026 (TTM): -5,33ย โ‚ฌ

According to Corbus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -5,64ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -5,45ย โ‚ฌ a decrease over its 2024 EPS that were of -3,34ย โ‚ฌ.

EPS history for Corbus Pharmaceuticals from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-5,33ย โ‚ฌ-2.2%
2025-5,45ย โ‚ฌ63.39%
2024-3,34ย โ‚ฌ
2022-9,26ย โ‚ฌ-13.16%
2021-10,67ย โ‚ฌ-73.65%
2020-40,48ย โ‚ฌ30.97%
2019-30,90ย โ‚ฌ15.31%
2018-26,80ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Viking Therapeutics
VKTX
-4,92ย โ‚ฌ-12.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-4,21ย โ‚ฌ-25.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-8,83ย โ‚ฌ 56.54%๐Ÿ‡บ๐Ÿ‡ธ USA